NCT01635530

Study of Lyme Neuroborreliosis

Study of Lyme Neuroborreliosis: Epidemiology, Manifestations, Diagnostics and Treatment

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 210 (actual)
• Sponsor: Turku University Hospital · Other Government
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

The main purpose of this study is to determine whether four weeks treatment with oral doxycycline is as equally effective as three weeks treatment with intravenous ceftriaxone in patients with Lyme neuroborreliosis. The other purpose is to improve laboratory diagnostics of Lyme neuroborreliosis and further define the manifestations and epidemiology of the disease in Finland.

Conditions

• Lyme Neuroborreliosis

Interventions

Type	Name	Description
DRUG	Doxycycline	Doxycycline: 100mg tablet two times per day, four weeks
DRUG	Ceftriaxone	2 g intravenous once a day, three weeks

Timeline

• Start date: 2012-08-01
• Primary completion: 2017-12-31
• Completion: 2018-12-31
• First posted: 2012-07-09
• Last updated: 2019-05-13

Locations

2 sites across 1 country: Finland